Search
Now showing items 1-4 of 4
Long-Term Experience Providing Antiretroviral Drugs in a Fee-for-Service HIV Clinic in Uganda
(Wolters Kluwer Health, Inc., 2005-04-15)
Objective:
To describe the long-term experience of providing anti-retroviral (ARV) therapy, including CD4+ cell count and virologic response, at St. Francis Hospital, Nsambya, Uganda.
Methods:
The HIV clinic established ...
Development of Phenotypic and Genotypic Resistance to Antiretroviral Therapy in the UNAIDS HIV Drug Access Initiative – Uganda
(Wolters Kluwer Health, Inc., 2003-07)
Objective: We describe phenotypic drug resistance, response to therapy, and geno-typic mutations among HIV-infected patients in Uganda taking antiretroviral medica-tions for ≥ 90 days who had a viral load ≥ 1000 ...
Assessment of a Pilot Antiretroviral Drug Therapy Programme in Uganda: Patients' Response, Survival, and Drug Resistance
(Elsevier, 2002-07-06)
Background
Little is known about how to implement antiretroviral treatment programmes in resource-limited countries. We assessed the UNAIDS/Uganda Ministry of Health HIV Drug Access Initiative—one of the first pilot ...
Therapeutic Responses to AZT 1 3TC 1 EFV in Advanced Antiretroviral Naive HIV Type 1-Infected Ugandan Patients
(Mary Ann Liebert, Inc., 2004-07-05)
Convenient, non-food-dependent dosing, low tablet volume, and relatively low cost have made nonnucleoside reverse transcriptase inhibitors a first choice for both clinicians and patients in Uganda. Concerns exist as to ...